Schuyler County to Consider Joining New $97.6 million Opioid Settlement

 The Schuyler County Legislature will review and consider a resolution authorizing participation in a new national opioid settlement at its meeting on Monday, April 13, 2026.

The proposed resolution would authorize Schuyler County Attorney Steven Getman to finalize the county’s participation in a settlement with six regional pharmaceutical distributors, collectively referred to as the “Remnant Defendants.” The agreement, if finalized, would resolve the county’s claims against those entities while allowing litigation against remaining defendants to continue.

According to Getman, under the proposed agreement, the six defendants will collectively pay approximately $97.6 million nationwide to support opioid abatement efforts. Each participating municipality, including Schuyler County, will receive a one-time payment. The specific amount allocated to Schuyler County is still being calculated based on a national formula, he said.

The measure has already advanced through the county’s committee process, receiving approval from the Management and Finance Committee on March 23, 2026, and the Legislative Resolution Review Committee on April 8, 2026.

Funds from the settlement would be used for approved opioid abatement strategies, including prevention programs, treatment services, naloxone distribution, and support for vulnerable populations affected by opioid addiction.

“This proposed settlement represents another step forward in holding opioid distributors accountable while delivering meaningful resources to our community,” Getman said. “While the exact amount is still being determined, these funds will directly support evidence-based strategies to combat opioid addiction and its impacts in Schuyler County.”

Schuyler County Administrator Shawn Rosno emphasized the importance of continued investment in public health efforts.

“Schuyler County has remained committed to addressing the opioid crisis through litigation and collaboration,” Rosno said. “Participation in this settlement will help strengthen our ability to fund prevention, treatment and recovery programs that serve our residents at no additional costs to our taxpayers.”

Schuyler County began pursuing legal action related to the opioid crisis in 2017, when the Legislature authorized Getman to work with outside counsel to seek damages from opioid manufacturers and distributors.

In 2018, the county adopted a local law declaring the opioid epidemic a public nuisance and filed a comprehensive lawsuit against multiple opioid supply chain participants, including manufacturers, distributors and pharmacies.

Since 2021, Schuyler County has secured over $862,000 in opioid-related settlements, including $121,000 from Johnson & Johnson, $546,000 from distributors McKesson Corporation, Cardinal Health Inc., and AmerisourceBergen Drug Corporation, $41,000 from Actavis Inc., $116,000 from Teva Pharmaceutical Industries Ltd., and $38,000 from Sandoz Inc.

These settlements are part of a broader national effort to hold companies accountable for their role in the opioid crisis and to fund long-term recovery and prevention programs at the local level.

Schuyler County remains committed to pursuing additional claims in the ongoing litigation to address the opioid epidemic’s devastating impact, Getman said.

Schuyler County Joins Opioid Lawsuits Settlements Totaling Over $7B

Tue, September 23, 2025 by Lucas Day:

In a special session on Monday (09/22/25), the Schuyler County Legislature authorized County Attorney Steven Getman to execute legal documents finalizing two landmark settlement agreements addressing the opioid crisis, totaling more than $7 billion.

The agreements include a $720 million national settlement with eight pharmaceutical companies and a $7.4 billion settlement with Purdue Pharma and the Sackler family. The $720 million settlement involves Alvogen Inc., Amneal Pharmaceuticals Inc., Apotex Inc., Hikma Pharmaceuticals USA Inc., Indivior Inc., Mylan Pharmaceuticals Inc., Sun Pharmaceutical Industries Inc., and Zydus Pharmaceuticals (USA) Inc.

Schuyler County expects payments to begin as early as 2026, with New York State and its counties receiving up to $38.7 million collectively. The agreement also includes injunctive relief prohibiting certain opioid marketing practices and provides opioid addiction treatment medications or equivalent cash payments valued at approximately $86 million.

The $7.4 billion Purdue Pharma and Sackler family settlement ends the Sacklers’ control of Purdue and bars them from selling opioids in the United States. The settlement, implemented through Purdue’s ongoing bankruptcy proceedings, includes a $6.5 billion contribution from the Sackler family over 15 years, with $1.5 billion paid in the first year. Funds will support opioid addiction treatment, prevention, and recovery programs in Schuyler County and communities nationwide over the next 15 years. A board of trustees, selected by participating states and creditors, will determine Purdue’s future, with oversight by a monitor to prevent opioid lobbying or marketing.

“These settlements mark a significant step toward continued accountability for the opioid crisis that has devastated our communities,” said Steven J. Getman, Schuyler County Attorney. “The funds will provide critical resources for treatment and prevention, and the injunctive relief ensures these companies can no longer fuel addiction through allegedly deceptive practices.”

Read more at the link above.

Summons and Complaint: The County of Schuyler v Purdue Pharma L.P. by Steven Getman

Schuyler County in line to receive $362,000 opioid settlement

Three national pharmacy chains—CVS, Walgreens, and Walmart--will pay Schuyler County up to $362,000 to settle claims the companies contributed to the ongoing opioid crisis in that county, under a settlement agreement to be voted on by the Schuyler County Legislature at its April meeting.

 

On Monday (March 27), the county’s Management and Finance Committee, chaired by Watkins Glen legislator Phillip Barnes, voted to recommend the settlement and authorized Schuyler County Attorney Steven Getman to execute the necessary legal documents upon approval by the Schuyler County Legislature.  The legislature will consider the measure on Monday (April 10).

 

The county is estimated to receive $125,031 from CVS, $158,486 from Walgreens and $79,038 from Walmart, Getman said.

 

According to Getman, the three companies all agreed to the settlement with the county as a part of a nationwide agreement to resolve all opioid litigation brought by states and local political subdivisions, including a pending lawsuit filed by the county, as well as later claims brought by the New York State Attorney General’s office. The agreement calls for the three chains to pay the county over the next fifteen years, with payments expected to begin in late 2023. 

 

Getman said that the settlement funds can be used for a variety of purposes.

 

“Potential uses include treating opioid addiction, law enforcement expenditures, funding social services and similar anti-drug efforts,” Getman explained.

The proposed settlement also orders the companies to implement changes to prevent fraudulent prescriptions, Getman noted.  Those changes include the companies addressing their compliance structures, pharmacist judgment, diversion prevention, suspicious order monitoring, and reporting on blocked and potentially problematic prescribers.

If approved, the agreement would be one of several opioid settlements Schuyler County has been a part of over the past five years.  In 2021, the county legislature authorized Getman to accept up to $121,000 from Johnson & Johnson and up to $546,000 from distributors McKesson Corporation, Cardinal Health Inc. and Amerisource Bergen Drug Corporation to treat, reduce and prevent opioid abuse.  A similar agreement, for $41,000, was obtained from defendant Actavis, Inc. in early 2022.  In January, the county legislature authorized Getman to accept up to $116,000 from Teva Pharmaceutical Industries Ltd. 

 

If these latest agreements are approved, the county will be in line to receive nearly $1.2 million total to date for opioid prevention and remediation.

 

“One cannot put a price on lives lost and families torn apart,” Getman said, “but with nearly $1.2 million expected to be delivered to Schuyler County, we can provide our community with financial assistance to continue this battle and hold these companies responsible for their role in the opioid epidemic.”

 

The settlements stem from a 2018 lawsuit the county filed against approximately thirty defendants, including some of the biggest names in the pharmaceutical industry. The lawsuit alleged the defendants had long known that opioids were addictive and subject to abuse, particularly when used long-term for chronic non-cancer pain, and should not be used except as a last-resort. However, the lawsuit stated, the defendants spent hundreds of millions of dollars disseminating scientific materials and advertising that misrepresented the risks of  long-term opioid use.

 

Schuyler County was one of many local governments that filed lawsuits against the manufacturers and distributors of opioid pain killers. At least 14 counties across New York sued the pharmaceutical companies for fraudulent marketing practices.

 

After the counties sued, in March 2019, the New York State Attorney General’s office brought its own lawsuit on behalf of the state.   In 2021, Attorney General Letitia James championed legislation to create an opioid settlement fund and in 2022 she announced a tentative deal with CVS, Walgreens and Walmart that she says will deliver over $13 Billion for communities nationwide to combat the opioid crisis.

 

Schuyler County’s lawsuit against other defendants remains pending, Getman said, with the possibility of more settlements and additional funding to the county still to come.  

 

The three companies involved in the latest proposed agreement have each issued their own statements denying liability and supporting settlement.

 

Resolution No. 21 (Intro), ... by Steven Getman

Opioid distributor Teva to pay up to $116,000 in settlement with Schuyler County

A major drug distributor and its subsidiaries will pay Schuyler County up to $116,000 to settle claims it contributed to the ongoing opioid crisis in that county, under a resolution approved by the Schuyler County Legislature at a special meeting.

Meeting on Monday (January 23), the legislature voted unanimously to accept the settlement and authorized Schuyler County Attorney Steven Getman to execute the necessary legal documents.

According to the resolution, distributor Teva Pharmaceutical Industries Ltd. and its subsidiaries (Teva Pharmaceuticals USA, Inc., the Actavis Generic Entities, and Anda, Inc.), agreed to the settlement with the county in exchange for being released from a pending lawsuit filed by the county, as well as later claims brought by the New York State Attorney General’s office.

The agreement calls for Teva to pay the county over seventeen annual installments, with payments expected to begin later this year, Getman said.

According to Getman, the settlement funds can be used for a variety of purposes.

“Potential uses include supporting police and first responders, treating opioid addiction, funding social services and similar anti-drug efforts,” Getman explained.

The agreement also commits Teva to critical injunctive relief, Getman noted, including:

• A ban on high-dose opioids and prescription savings programs;
• Prohibitions on marketing opioids and funding third parties that promote opioids;
• Restrictions on political lobbying; and
• Disclosure of Teva opioid product clinical data.

The motion authorizing Getman to accept the settlement was made by County Legislator Phil Barnes (R, Watkins Glen) and seconded by Legislator Michael Lausell (D, Hector).

The Teva agreement is the latest opioid settlement Schuyler County has been a part of in the past five years. In 2021, the county legislature authorized Getman to accept up to $121,000 from Johnson & Johnson and up to $546,000 from distributors McKesson Corporation, Cardinal Health Inc. and Amerisource Bergen Drug Corporation to treat, reduce and prevent opioid use through a court settlement with the opioid maker. A similar agreement, for $41,000, was obtained from defendant Actavis, Inc. in early 2022. Like the Teva agreement, payments to the county are scheduled to be made over time.

The settlements stem from a 2018 lawsuit the county filed against approximately thirty defendants, including some of the biggest names in the pharmaceutical industry. The lawsuit alleged the defendants had long known that opioids were addictive and subject to abuse, particularly when used long-term for chronic non-cancer pain, and should not be used except as a last-resort. However, the lawsuit stated, the defendants spent hundreds of millions of dollars disseminating scientific materials and advertising that misrepresented the risks of opioids’ long-term use.

Schuyler County was one of many local governments that filed lawsuits against the manufacturers and distributors of opioid pain killers. At least 14 counties across New York sued the pharmaceutical companies for fraudulent marketing practices.

After the counties sued, in March 2019, the New York State Attorney General’s office brought its own lawsuit on behalf of the state. In November, 2022, Attorney General Letitia James announced a tentative deal with Teva that will deliver up to $523 million to New York state to combat the opioid epidemic.

In October 2017, the U.S. Department of Health and Human Services declared a public health emergency due to the consequences of the opioid crisis facing the nation. That year, more than 70,000 individuals nationally and nearly 4,000 New Yorkers lost their lives to a drug overdose.

Schuyler County’s lawsuit against a number of other defendants remains pending, Getman said, with the possibility of more settlements and additional funding to the county still to come.

Said Getman: “One cannot put a price on lives lost and families torn apart, but with the more than $824,000 expected to be delivered to Schuyler County from these lawsuits, we can provide the County with financial assistance to continue this battle and hold these companies responsible for their role in the opioid epidemic.”

County Administrator Fonda Chronis agreed: "County officials have expended significant resources to help its residents battle opioid addiction and prevent further deaths. By voting to go forward with this settlement, the County Legislature hopes to lessen the burden to taxpayers for expenses related to the opioid crisis."

Schuyler County’s latest salvo in the fight against opioid companies comes shortly after the New York State Department of Health released its Quarterly Opioid Report for January 2023, showing a 14% increase in 2021 overdose deaths involving opioids compared to 2020. That report, comparing state totals for 2021 to 2020 data, noted a 14% increase in overdose deaths involving opioids, with 4,766 deaths statewide in 2021. The report notes that fentanyl has contributed to an increase in opioid overdose deaths in recent years, is 50 to 100 times stronger than heroin, and is now involved in the majority of overdose deaths in New York State.

In November, Teva issued a statement describing the settlement as "enabling us to put these cases behind us and continue to focus on the patients we serve every day.”

New Laws Meant to Combat the Opioid Crisis in New York State

New York State has enacted a package of bills “designed to remove barriers to drug treatment and make substance abuse prevention resources available to more New Yorkers.”

According to Governor Kathy Hochul, the new laws are “aimed toward reducing drug-related overdose deaths across New York State and encouraging those suffering from addiction to seek help in their recovery.”

The laws include:

• S911/A2354, amending the CPL, the CPLR, and the Executive Law “to promote the use of opioid antagonists in preventing drug-related overdoses,” by decriminalizing possession of opioid antagonists, “drugs that block opioids by attaching to opioid receptors without activating them.”
• S6044/A128, establishing “an online directory for distributors of opioid antagonists making them more accessible to New Yorkers ….” • S2523/A868, decriminalizing “the possession and sale of hypodermic needles and syringes.”
• S7228/A5511-A, expanding “the number of eligible crimes committed by individuals with a substance use disorder that may be considered for diversion to a substance use treatment program” and updating “the term ‘substance abuse’ to ‘substance use.’”
• S.1795/A.533 Relates to the Establishment of a Program for the Use of Medication Assisted Treatment for Incarcerated Individuals

Some local law enforcement officials in the state have criticized the bills as an “unfunded mandate” on counties that won’t solve the problem as intended:

Lewis County Sheriff Mike Carpinelli, who is running for governor as a Republican, said “I’m upset by it. I think it’s a waste of taxpayers’ money, and I think it’s gonna bring more problems to all our jails across the state.” “Why instead of actually treating the addiction problem are we giving them something that enables them to continue on with it?” he said. ****
Brooks Bigwarfe, St. Lawrence County Sheriff, and Colleen O’Neill, Jefferson County Sheriff, said they’ll follow the state’s orders. Both declined to offer an opinion about the wisdom of the new law…. Bigwarfe, like Carpinelli, pointed out that it’s an unfunded state mandate, so taxpayers will be paying for the new program.

More on the new laws can be found here.

Three opioid distributors to pay up to $546,000 in settlement with Schuyler County

Three major drug distributors will pay Schuyler County up to $546,000 to settle claims they contributed to the ongoing opioid crisis in that county, under a resolution approved by the Schuyler County Legislature at its October monthly meeting.

Meeting on Tuesday (October 12), the county legislature voted unanimously to accept the settlement and authorized Schuyler County Attorney Steven Getman to execute the necessary legal documents.

According to the resolution, distributors McKesson Corporation, Cardinal Health Inc. and Amerisource Bergen Drug Corporation all agreed to the settlement with the county in exchange for being released from a pending lawsuit filed by the county, as well as later claims brought by the New York State Attorney General’s office.

The agreement calls for the three distributors to pay the county over eighteen annual installments, with payments expected to begin in 2022, Getman said.

According to Getman, the settlement funds can be used for a variety of purposes.

“Potential uses include supporting police and first responders, treating opioid addiction, funding social services and similar anti-drug efforts,” Getman explained.

The settlement also requires the distributors to implement a process for collecting and analyzing data about opioid sales, Getman noted. It will involve the creation by the companies of a data clearinghouse to establish pharmacy-specific opioid shipment limits that each distributor must follow to properly monitor opioid data.

The motion authorizing Getman to accept the settlement was made by County Legislator Phil Barnes (R, District VI) and seconded by Legislator Mark Rondinaro (R, District VII).

It is the second opioid settlement Schuyler County has been a part of in the past two months. In September, the county legislature authorized Getman to accept up to $121,000 from Johnson & Johnson, the parent company of Janssen Pharmaceuticals, Inc., to treat, reduce and prevent opioid use through a court settlement with the opioid maker.

The settlements stem from a 2018 lawsuit the county filed against approximately thirty defendants, including some of the biggest names in the pharmaceutical industry. The lawsuit alleged the defendants had long known that opioids were addictive and subject to abuse, particularly when used long-term for chronic non-cancer pain, and should not be used except as a last-resort. However, the lawsuit stated, the defendants spent hundreds of millions of dollars disseminating scientific materials and advertising that misrepresented the risks of opioids’ long-term use.

Schuyler County was one of many local governments that filed lawsuits against the manufacturers and distributors of opioid pain killers. At least 14 counties across New York sued the pharmaceutical companies for fraudulent marketing practices.

After the counties sued, in March 2019, the New York State Attorney General’s office brought its own lawsuit on behalf of the state. In July, Attorney General Letitia James announced a tentative deal with the three drug distributors that will deliver up to $1.1 billion to New York state to combat the opioid epidemic. Since then, James has begun a statewide “HealNY” tour related to highlight the settlements, with stops throughout the state, including New York City, Utica and Syracuse.

Schuyler County’s lawsuit against other defendants remains pending, Getman said, with the possibility of more settlements and additional funding to the county still to come. Along with the three distributors and Johnson & Johnson, the defendants named in the county’s lawsuit include: Purdue Pharma L.P.; Teva Pharmaceuticals USA, Inc.; Cephalon, Inc.; Endo Pharmaceuticals, Inc.; Actavis Pharma, Inc. and Insys Therapeutics, Inc.

The three companies named in Tuesday’s resolution have issued a joint statement "strongly disputing" any wrongdoing. They described the settlements as "an important step toward finalizing a broad settlement" with states, counties, and local municipalities.

New York Court allows opioid claims to go forward against current, former directors of Purdue Pharma

Central Islip, NY--A New York State Supreme Court judge has denied a motion to dismiss cases brought by multiple New York municipalities, including Schuyler County, against current and former directors of opioid manufacturer Purdue Pharma.

In a ruling filed Friday (June 21), Justice Jerry Garguilo found thirty-one counties and two cities had alleged sufficient facts to move forward against various members of the Sackler family in order to recoup millions of dollars in costs tied to the opioid crisis.

Among the local counties and cities making claims are Schuyler County, Seneca County, Steuben County, Tompkins County and the City of Ithaca.

According to Schuyler County Attorney Steven Getman, Schuyler County's claims include public nuisance, negligence, fraud and false advertising. 

Pursuant to the June 21 decision, the Sackler family had argued that they were not vicariously liable for the acts of Purdue’s board of directors and that the cities and counties had failed to allege that any of them participated in making the alleged misstatements in the complaint.

However, Garguilo found that, under New York law, directors may be held individually liable for a company’s tort action if they “directed, controlled, approved or ratified” the decision that lead to the injuries.

The complaint, the judge noted, alleged the Sacklers, as “controlling directors” of Purdue, oversaw the company’s marketing and targeting of doctors.  The Sacklers include former Purdue Chair and president Richard Sackler and seven other members of the family.

A public nuisance claim, the judge wrote, “may be an appropriate tool to address the consequential harm from the defendants’ concerted efforts to market and promote their products for sale and distribution, particularly as such efforts are alleged to have created or contributed to a crisis of epidemic proportions.”

Therefore, Garguilo allowed the cases to go forward, pending further discovery and other pretrial proceedings.

One such case was recently brought by Schuyler County. In August 2017, the County Legislature voted to retain the firm of Napoli Shkolnik to work with Getman, as special counsel, to bring an action against the manufacturers and distributers of prescription opiates for damages to the County. In May 2018, Getman filed a nearly 250-page Summons and Complaint for damages to the county. That case was transferred to Suffolk County Courts shortly thereafter, to join other cases brought by various New York state counties.  The counties later added the Sacklers as individual defendants.

“We applaud the court’s decision,” Getman said. “Schuyler County’s lawsuit will move forward to seek reimbursement for its expenses allegedly related to the opioid crisis as well as to provide the County with financial aid to fight addiction, overdoses, drug-related crimes and drug deaths.”

According to Schuyler County Administrator Tim O’Hearn, the lawsuit was filed at no risk to the county, as Napoli Shkolnik will work on contingency basis that will cover all costs associated with the lawsuit.

“By going forward with litigation, the County Legislature hopes to lessen the burden to taxpayers and hold manufacturers and distributors responsible for any role in the opioid epidemic,” O’Hearn said.

Schuyler County is one of several New York municipalities to file lawsuits against the manufacturers and distributors of opioid pain killers. At least thirty-three municipalities across the state are suing pharmaceutical companies for what they claim are deceptive marketing practices.

In addition, in February 2018, New York State officials filed a lawsuit against Insys Therapeutics, Inc., alleging that Insys deceptively promoted prescription opiate Subsys for unsafe uses and violated state law by downplaying drug’s addictive risks.

A copy of the court’s decision can be found here.

A copy of Schuyler County’s Summons and Complaint can be found here

Note: The allegations in a civil complaint are merely accusations and defendants are not considered culpable unless and until accusations are proven by a preponderance of evidence in a court of law.

$20 million federal fine against Rochester-area opioid distributor announced

One of the “big pharma” distributors of prescription opiates being sued by Schuyler County for fraudulent and negligent marketing and distribution of opiates will pay a $20 million fine under an settlement unveiled in federal court on Tuesday (April 23).

Rochester Drug Cooperative, Inc. (RDC), one of the nation's largest pharmaceutical distributors, was charged by federal prosecutors with conspiracy to distribute controlled narcotics — oxycodone and fentanyl — for non-medical reasons and conspiracy to defraud. Prosecutors allege that, from 2012 through March 2017, RDC knowingly and intentionally violated federal narcotics laws by distributing opioids to pharmacy customers that it knew were being sold and used illicitly.

According to court documents, the company has agreed to enter into a “consent decree,” under which it accepts responsibility for its conduct by making admissions and stipulating to an extensive "Statement of Facts," paying a $20 million penalty, reforming its controlled substances compliance program, and submitting to supervision by an independent monitor.

RDC is one of the big pharmaceutical companies being sued in state court by various New York municipalities, including Schuyler County. In May of last year, Schuyler County Attorney Steven Getman filed a nearly 250-page Summons and Complaint in New York State Supreme Court for damages to the county arising out of the fraudulent and negligent marketing and distribution of opiates in the county.

Getman said his office would be carefully reviewing the statement of facts for evidence that could be used to support the county’s lawsuit.

“Schuyler County’s complaint alleges increased opioid use has fueled an illegal secondary market for opioids and the criminals who support it,” Getman said. “It also alleges that the defendants flooded the county with suspiciously large amounts of opioids.”

“To date, county officials have expended significant resources to help its residents battle opioid addiction and prevent further deaths,” Getman said. “Schuyler County’s lawsuit is moving forward to seek reimbursement for expenses related to the opioid crisis as well as to provide the county with financial aid to fight addiction, overdoses, drug-related crimes and drug deaths.”

In 2017, the County Legislature voted to retain the firm of Napoli Shkolnik to work with Getman, as special counsel, to bring an action against the manufacturers and distributers of prescription opiates for damages to the county.

According to Schuyler County Administrator Tim O’Hearn, the lawsuit was filed at no risk to the County, as Napoli Shkolnik will work on contingency basis that will cover all costs associated with the lawsuit.

“By going forward with litigation, the County Legislature hopes to lessen the burden to taxpayers and hold manufacturers and distributors responsible for their role in the opioid epidemic,” O’Hearn said.

Schuyler County is one of several New York municipalities filing lawsuits against the manufacturers and distributors of opioid pain killers. At least 14 counties across New York are suing pharmaceutical companies for what they are claiming are deceptive marketing practices.

The consent decree is subject to final approval by the court. Any charges contained in complaints, indictments and other court documents are merely accusations, and any defendants are presumed innocent unless and until proven guilty in a court of law.

New report questions effectiveness of supervised drug consumption facilities

From the Washington Post:

(E)xisting research does not establish that drug users who access SDCFs are less likely to die of an overdose over time, or that opening an SDCF lowers a community’s rate of drug overdose fatalities...

The report found that many people use SDCFs intermittently, but do not adopt the safer use practices from SDCFs when using outside of it. An individual who injects heroin in the SDCF one day may thus avoid a fatal overdose that particular day, but have one the next day outside the SDCF. More importantly, no one knows whether becoming an SDCF user leads to longer drug use careers than do other interventions (e.g., methadone maintenance). If by making injection drug use safer and more positive (e.g., being surrounded by supportive people), SDCFs even modestly reduce the likelihood of an individual stopping injection use in the next week, or month, or year, the benefit of lower risk SDCF drug use now can be canceled out by an increased number of drug use episodes later.

Read the complete article here. Read the underlying report here.

The Opioid Crisis: See the Signs, Save a Life PSA

Help fight the opioid crisis on October 27: bring unused prescription drugs to a drop-off location on National Drug Takeback Day.

As part of Schuyler County’s multi-leveled approach to tackling the opioid epidemic, Schuyler County officials are encouraging community members to participate in National Drug Take Back Day on Saturday October 27.

According to Schuyler County Attorney Steven Getman, “the initiative is aimed at helping citizens take one of the simplest steps to prevent addiction: safely disposing of unused drugs at drop-off sites around the nation.”

“Statistics indicate that new heroin users start out by misusing prescription drugs,” Getman noted, “and a majority of abused prescription drugs were obtained from family and friends, often from a home medicine cabinet.”

Schuyler County residents can drop off their expired, unused, or unwanted medications between 10 AM and 2 PM at the Odessa and Tyrone Fire Stations. The Odessa Fire Station is located at 300 East Main Street in Odessa. The Tyrone Fire Station can be found at 3600 State Route 226 in Tyrone. Those drop-in stations are being sponsored by Schuyler County Sheriff William Yessman and the Schuyler County Coalition on Underage Drinking and Drugs (SCCUDD).

Community members can also dispose of unwanted, expired, and unused prescription drugs year-round by using the 24/7 confidential drop boxes available at the Schuyler County Sheriff’s Office in Watkins Glen or in the foyer at the Human Services Complex in Montour Falls.

Residents of other New York counties can visit clearyourcabinet.com to find out where they can safely dispose of medications this Saturday, Getman said. Disposal of unused prescriptions and over-the-counter medication at these locations is "no questions asked" and free of charge.

In addition to advancing efforts for the disposal of unused opioids, Schuyler County’s strategy to attack the national opioid epidemic includes its ongoing lawsuit against the manufacturers and distributers of prescription opiates for damages to the County. In May of this year, Getman filed a nearly 250-page Summons and Complaint for damages to the County arising out of the fraudulent and negligent marketing and distribution of opiates in the County. That case was transferred to Suffolk County Courts shortly thereafter, to join other cases brought by various New York state counties. In June, a New York State Supreme Court Judge refused to dismiss lawsuits against several large opioid manufacturers in one of the earliest decisions to come out of the cases brought by local governments over the prescription painkillers.

Recent reports indicate that opioids now kill more than 50,000 Americans a year, 10,000 more than AIDS did at the peak of that epidemic.

The National Prescription Drug Take Back Day is organized by the Federal Drug Enforcement Agency to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse of medications. Various national organizations have joined the DEA and local agencies in organizing the event, including the White House Office of National Drug Control Policy; the American Association of Poison Control Centers; the Community Anti-Drug Coalitions of America; D.A.R.E. America; the Federation of State Medical Boards; the U. S. Health Resources and Services Administration; the International Association of Chiefs of Police; the National Association of Attorneys General; the National Family Partnership; the National Organization of Black Law Enforcement Executives; the National Association of Boards of Pharmacy; the National District Attorneys Association; the National Sheriffs’ Association; and The Partnership at Drugfree.org.

For more information about Schuyler County’s participation in National Drug Take Back Day, click here.

New York State Supreme Court denies drug companies’ motions to dismiss counties’ Opioid cases

A New York State Supreme Court Judge has refused to dismiss lawsuits against several large opioid manufacturers in one of the first decisions to come out of the cases brought by local governments over the prescription painkillers.

In a pair of rulings on Monday (June 18), Suffolk County Supreme Court Justice Jerry Garguilo rejected motions to dismiss brought by Purdue Pharma, Endo Health Solutions, Teva Pharmaceuticals, Allergan, Johnson & Johnson’s Janssen Pharmaceuticals Inc. and Insys Therapeutics Inc.

“The plaintiffs allege the manufacturer defendants employed assiduously crafted, multi-pronged marketing strategies that targeted the general public … as part of their respective campaigns to change the perception of the risks associated with prescription opioids and to de-stigmatize and normalize the long-term use of opioids for chronic nonmalignant pain,” he wrote.

Therefore, Garguilo allowed cases brought by various New York counties to go forward alleging violations of New York’s fraud and false advertising laws, as well as public nuisance and other claims.

One such case has been brought by Schuyler County. In August 2018, the County Legislature voted to retain the firm of Napoli Shkolnik to work with Schuyler County Attorney Steven Getman, as special counsel, to bring an action against the manufacturers and distributers of prescription opiates for damages to the County. In May of this year, Getman filed a nearly 250-page Summons and Complaint for damages to the County arising out of the fraudulent and negligent marketing and distribution of opiates in the County. That case was transferred to Suffolk County Courts shortly thereafter, along with other cases brought by New York counties in the state.

“We are obviously pleased by the court’s decision,” Getman said. “This is one of the first decisions to fully address all the substantive arguments in these various cases, and the court issued a well-thought-out opinion covering many of the issues raised throughout the state, including in our case. We consider it valuable precedent.”

“Schuyler County’s lawsuit will move forward to seek reimbursement for its expenses related to the opioid crisis as well as to provide the County with financial assistance to fight addiction, overdoses, drug-related crimes and drug deaths,” Getman stated.

According to Schuyler County Administrator Tim O’Hearn, the lawsuit was filed at no risk to the County, as Napoli Shkolnik will work on contingency basis that will cover all costs associated with the lawsuit.

“By going forward with litigation, the County Legislature hopes to lessen the burden to taxpayers and seeks to hold manufacturers and distributors responsible for their role in the opioid epidemic,” O’Hearn said.

Schuyler County is one of several New York municipalities to file a lawsuit against the manufacturers and distributors of opioid pain killers. At least 14 counties across New York are suing pharmaceutical companies for what they're claiming are deceptive marketing practices. In addition, in February, New York State officials filed a lawsuit against Insys Therapeutics, Inc., alleging that Insys deceptively promoted prescription opiate Subsys for unsafe uses and violated state law by downplaying drug’s addictive risks.

New York State Opioid Litigation Part 48, Suffolk County orders June 18, 2018. by Steven Getman on Scribd

(2023 Note to Blogger content moderation algorithm: this post is about a lawsuit against certain companies, not an attenpt to "sell, advertise, or facilitate the sale of regulated goods and services. Regulated goods and services include alcohol, gambling, pharmaceuticals, unapproved supplements, tobacco, fireworks, weapons, or health/medical devices."

Schuyler County files lawsuit against the manufacturers and distributors of opioid pain killers.

Schuyler County officials are formally taking “big pharma” to court.

On Friday (May 11, 2018), Schuyler County Attorney Steven Getman filed a nearly 250-page Summons and Complaint against manufacturers and distributers of prescription opiates for damages to the County arising out of the fraudulent and negligent marketing and distribution of opiates in and to the County.

“Over the past few years, despite its small population, Schuyler County has seen an uptick in opioid and heroin use and overdose,” Getman said. “To date, County officials have expended significant resources to help its residents battle opioid addiction and prevent further deaths. The lawsuit will seek to reimburse the County for its expenses related to the opioid crisis as well as provide the County with financial assistance to continue this battle.”

The Summons names approximately thirty defendants, including some of the biggest names in the pharmaceutical industry, such as: Purdue Pharma L.P.; Teva Pharmaceuticals USA, Inc.; Cephalon, Inc.; Johnson & Johnson; Janssen Pharmaceuticals, Inc.; Endo Pharmaceuticals, Inc.; Actavis Pharma, Inc. and Insys Therapeutics, Inc.

The Complaint alleges the defendants knew--and had known for years–that opioids were addictive and subject to abuse, particularly when used long-term for chronic non-cancer pain, and should not be used except as a last-resort. However, the Complaint alleges, the defendants spent hundreds of millions of dollars disseminating scientific materials and advertising that misrepresented the risks of opioids’ long-term use.

“The United States is now awash in opioids,” the Complaint says.

Summons and Complaint: The County of Schuyler v Purdue Pharma L.P. by Steven Getman on Scribd

Schuyler County is the latest New York State county to file a lawsuit against the manufacturers and distributors of opioid pain killers. At least 14 counties across New York are suing pharmaceutical companies for what they're claiming are deceptive marketing practices. In addition, in February, New York State officials filed a lawsuit against Insys Therapeutics, Inc., alleging that Insys deceptively promoted prescription opiate Subsys for unsafe uses and violated state law by downplaying drug’s addictive risks.

Schuyler County Proposed Local Law: Notice of Public Hearing

PLEASE TAKE NOTICE that a public hearing shall be held upon the following proposed Local Law on March 12, 2018 at 6:30 p.m. in the County Office Building, 105 Ninth Street, Watkins Glen, NY:

Local Law B of the year 2018: A Local Law declaring the opioid epidemic and its effects on the County a public nuisance and establishing a cost recovery procedure.

Purpose and intent.

A. The opioid epidemic is sweeping the country. Indeed, addiction to and abuse of opioids is one of the greatest challenges facing Schuyler County, New York (the “County”). A cause of this increasing crisis is the overabundance of prescription opioids. Large amounts of prescription opioids were sold, distributed, and prescribed in the County over the past several years, a practice that continues today. The selling, distributing, and prescribing of large amounts of opioids in our community has created a public health and safety hazard affecting the residents of the County. This crisis has devastated families, wreaked havoc on our economy, and produced a generation of narcotic dependence. As a result of the opioid epidemic, costs related to healthcare, family and social services, criminal justice, addiction and rehabilitation, and many other areas have significantly increased. Many of these costs are paid by the County.

B. The purpose and intent of this legislation is to allow the County to recover these costs, despite the existence of the common-law municipal cost recovery rule (a.k.a. free public services doctrine) and declare the opioid epidemic and its effects on the County a public nuisance. Specifically, the County provides services related to the opioid epidemic, which are funded by tax revenues. This statute clarifies that reimbursement may be sought for the costs of providing such services, whenever practicable, from the responsible party. To accomplish this, the County establishes this cost recovery procedure and declares the opioid epidemic and its effects on the County a public nuisance.

The complete text of the proposed local law can be found here.

Schuyler County Opioid Lawsuit Fight Continues Forward. Public Hearing Scheduled on Local Law to Declare the Opioid Epidemic a Public Nuisance.

Schuyler County will hold a public hearing on March 12 to review a proposed local law declaring the opioid epidemic and its effects on the County a public nuisance.

According to Schuyler County Attorney Steven Getman, the draft local law is the next step in the County’s lawsuit against the manufacturers and distributors of opioid pain killers.

“The purpose and intent of this legislation is to allow the County to recover costs related to healthcare, family and social services, criminal justice, addiction and rehabilitation, and many other areas have significantly increased,” Getman explained.   “Many of these costs are paid by the County.”

Upon passage, the local law would be followed by the filing of a lawsuit against the manufacturers and distributers of prescription opiates for damages to the County arising out of the fraudulent and negligent marketing and distribution of opiates in and to the County

The County Legislature voted in August to retain the firm of Napoli Shkolnik, PLLC to file that lawsuit on their behalf.  Napoli Shkolnik will work with Getman, as special counsel. 

“Over the past few years, despite its small population, Schuyler County has seen an uptick in opioid and heroin use and overdose,” Getman said.   “To date, County officials have expended significant resources to help its residents battle opioid addiction and prevent further deaths. The lawsuit will seek to reimburse the County for its expenses related to the opioid crisis as well as provide the County with financial assistance to continue this battle.”

According to County Administrator Tim O’Hearn, the lawsuit will be filed at no risk to the County, as Napoli Shkolnik will work on contingency basis that will cover all costs associated with the lawsuit.

“By voting to go forward with local law, the County Legislature hopes to lessen the burden to taxpayers and seeks to hold manufacturers and distributors responsible for their role in the opioid epidemic,” O’Hearn said.  

  

“These drug companies have poisoned our communities and polluted our children” says Paul Napoli, of counsel for Napoli Shkolnik. Paul Napoli leads the charge with Hunter Shkolnik against drug companies nationwide.

“The painkiller overdose epidemic is a classic case of putting profits before people,” he said. “Many opioid manufacturers were so intent on selling as much product as possible that they either turned a blind eye towards, or intentionally buried, reports that these drugs were highly addictive and potentially deadly.”

Napoli added that “our door is open” to other New York municipalities who are also fed up with the overdose epidemic, and that Napoli Law has the firepower to go toe-to-toe with the big pharma lawyers.

Napoli has dedicated much of his career to mass tort litigation. He has fought on behalf of 9/11 injury victims at both the statehouse and the courthouse, and he and his team also took on the big energy companies which contaminated much of Long Island’s drinking water supply with dangerously high levels of methyl tertiary butyl ether.

The Public Hearing on the proposed local law will be held in the Legislative Chambers of the Schuyler County Courthouse, 105 Ninth Street, Watkins Glen, New York on Monday, March 12, 2018 at 6:30 pm.   The public is invited and encouraged to attend and voice their concerns regarding the opioid epidemic and the costs to Schuyler County and its communities.

A copy of the proposed local law, as introduced February 12, 2018, can be found here.

Latest Efforts to Curb Opioid Epidemic in NY: Controlled Substance Schedule Changes

New York State officials have announced a budget amendment will be advanced to add 11 fentanyl analogs to the state controlled substances schedule and provide the New York State Health Commissioner the authority to add any new drugs that have been added to the federal schedule, to the state controlled substances schedule.

These actions are intended support law enforcement in their efforts to stop the spread of lethal drugs in New York State.

In recent years, fentanyl analogs have been increasingly found pressed into pill form to resemble name-brand prescription opioids, and in heroin and cocaine being sold in New York State. Compared to 30 milligrams of heroin, just three milligrams of fentanyl can be fatal.

There is currently a loophole in state law that has left 11 dangerous fentanyl analogs off New York's controlled substances schedule.

For more on this initiative, click here.

For more on the Schuyler County Attorney's efforts to thwart opioid abuse, click here.

Doctor who operated a Pill Mill for persons addicted to opioids convicted of Manslaughter for overdose deaths

The New York State Supreme Court, Appellate Division First Department, has determined that a doctor accused of operation of a "pill mill" for persons addicted to opioids and Xanax, was properly convicted of manslaughter in the overdose deaths of two persons to whom he had supplied drugs:

At bottom, all that was needed for the manslaughter charge to be sustained was for the People to satisfy its elements. That is, that defendant was 'aware of and consciously disregard[ed] a substantial and unjustifiable risk that [death] [would] occur . . . The risk [being] of such nature and degree that disregard thereof constitute[d] a gross deviation from the standard of conduct that a reasonable person would observe in the situation' ... . The question then becomes whether the People presented sufficient evidence to establish that defendant consciously disregarded the risk that [the addicts] would die as a result of his prescribing practices. ...

People v. Stan XuHui Li, 2017 N.Y. Slip Op. 08438, First Dept 11-30-17

Institute for Advancing Justice on October 26, 2017

In looking to the future of criminal justice reform and the achievements of the last few years, the Charles Koch Institute is hosting “Advancing Justice 2017,” a one-day conference to be held in Washington, DC on Thursday, October 26, 2017.

Advancing Justice will offer attendees the opportunity to learn more about issues critical to the reform agenda – including the opioid crisis, collateral consequences, mens rea, and the future of federal sentencing.

Additional information about the schedule of events and confirmed speakers is available here.

Obituaries reflect devastating opioid crisis, as families tell truth about lost loved ones: Parents who have lost children to drug overdoses use obituaries to share the family's struggle with addiction.

Schuyler County Joins Growing List of New York Counties Against Opioids

Schuyler County has become the latest New York State county to take action against the manufacturers and distributors of opioid pain killers.

The County Legislature voted Monday (August 14) to retain the firm of Napoli Shkolnik, PLLC to file a lawsuit on their behalf. Schuyler County joins other New York Counties and numerous municipalities nationwide already represented by Napoli Shkolnik.

Napoli Shkolnik will work with Schuyler County Attorney Steven J. Getman, as special counsel, to bring an action against the manufacturers and distributers of prescription opiates for damages to the County arising out of the fraudulent and negligent marketing and distribution of opiates in and to the County

“Over the past few years, despite its small population, Schuyler County has seen an uptick in opioid and heroin use and overdose,” Getman said. “To date, County officials have expended significant resources to help its residents battle opioid addiction and prevent further deaths. The lawsuit will seek to reimburse the County for its expenses related to the opioid crisis as well as provide the County with financial assistance to continue this battle.”

According to County Administrator Tim O’Hearn, the lawsuit will be filed at no risk to the County, as Napoli Shkolnik will work on contingency basis that will cover all costs associated with the lawsuit.

“By voting to go forward with litigation, the County Legislature hopes to lessen the burden to taxpayers and seeks to hold manufacturers and distributors responsible for their role in the opioid epidemic,” O’Hearn said.

“For many years the manufacturers and distributors of opioid pain medications have earned billions of dollars in profits flooding this Country with opioids” says Napoli Shkolnik attorney Joseph L. Ciaccio, “these lawsuits seek to force those companies to help clean up the devastation caused by these pills.”

“These drug companies have poisoned our communities and polluted our children” says Paul Napoli, of counsel for Napoli Shkolnik. Paul Napoli leads the charge with Hunter Shkolnik against drug companies nationwide.

“The painkiller overdose epidemic is a classic case of putting profits before people,” he said. “Many opioid manufacturers were so intent on selling as much product as possible that they either turned a blind eye towards, or intentionally buried, reports that these drugs were highly addictive and potentially deadly.”